focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Tue, 23rd Apr 2019 16:03

Wednesday 24 April 
PetropavolskFull Year Results
Boohoo GroupFull Year Results
Puretech HealthFull Year Results
MaxcyteFull Year Results
AB DynamicsHalf Year Results
WandiscoFull Year Results
CRHTrading Statement
Associated British FoodsHalf Year Results
AntofagastaQ1 Production
Croda InternationalQ1 Results
CentaminQ1 Results
Thursday 25 April 
Acacia MiningQ1 Results
RELXTrading Statement 
Anglo AmericanQ1 Production
DevroTrading Statement 
RDI REITHalf Year Results
Tullow OilTrading Statement 
BarclaysQ1 Results
KAZ MineralsQ1 Results
SeniorTrading Statement 
MeggittTrading Statement 
Taylor WimpeyTrading Statement 
SynthomerTrading Statement 
CarpetrightTrading Statement 
Friday 26 April  
WPPQ1 Results
Hastings GroupQ1 Results
Allied MindsFull Year Results
ComputacenterQ1 Results
RotorkTrading Statement 
Royal Bank of Scotand GroupQ1 Results
Just EatQ1 Results
AstraZenecaQ1 Results
AJ BellTrading Statement 
Georgia CapitalQ1 Results
Monday 29 April 
EvrazQ1 Results
UP Global SourcingHalf Year Results
Horizon Discovery GroupFull Year Results
River & MerantileQ3 Results
Tuesday 30 April 
BPQ1 Results
Standard CharteredQ1 Results (at 0515 BST)
ElementisTrading Statement 
GlencoreQ1 Production
St James's PlaceQ1 Results
WhitbreadFull Year Results
Weir GroupQ1 Results
Breedon GroupTrading Statement 
Jupiter Fund ManagementQ1 Results
Hochschild MiningQ1 Production
Greene KingTrading Statement 
C4X DiscoveryHalf Year Results
AnimalcareFull Year Results
Xeros Technology GroupFull Year Results
FocusriteHalf Year Results
  

More News
7 May 2020 17:57

C4X Discovery Raises GBP1.6 Million Via Share Placing

C4X Discovery Raises GBP1.6 Million Via Share Placing

Read more
24 Jan 2020 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jan 2020 10:40

C4X Discovery Annual Loss Widens, Confident In Strategy

C4X Discovery Annual Loss Widens, Confident In Strategy

Read more
7 Jan 2020 09:59

C4X losses widen as its revenue drops to nil

(Sharecast News) - Drug discovery company C4X Discovery Holdings announced a fall in revenue to nil in its full-year results on Tuesday, from £7.06m in 2018, which the board said as driven entirely by the Indivior licensing agreement in that year.

Read more
31 Dec 2019 10:47

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
24 Oct 2019 17:06

UPDATE: C4X Discovery Raises GBP7 Million In Discounted Placing

UPDATE: C4X Discovery Raises GBP7 Million In Discounted Placing

Read more
24 Oct 2019 11:09

C4X Discovery Raises Over GBP5 Million In Discounted Placing

C4X Discovery Raises Over GBP5 Million In Discounted Placing

Read more
24 Oct 2019 10:31

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

Read more
1 Oct 2019 10:15

C4X makes solid progress across portfolio of programmes

(Sharecast News) - Drug discovery company C4X Discovery Holdings announced progress across a number of key programmes in line with its strategy on Tuesday, reporting that it was continuing to progress its strategy to deliver programmes for out-licensing its NRF-2 activator, IL-17 inhibitor and LifeArc collaboration.

Read more
27 Sep 2019 15:39

C4X upbeat as its molecule progresses with Indivior

(Sharecast News) - Drug discovery company C4X Discovery Holdings noted an announcement on Friday that the National Institutes of Health (NIH) in the United States has granted Indivior's application titled "Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder'.

Read more
2 Sep 2019 12:02

Former Glaxo Vice President To Lead C4X Discovery Advisory Network

(Alliance News) - C4X Discovery Holdings PLC on Monday said it is forming a drug discovery advisory network chaired by "renowned industry veteran" Robin Carr.Shares in C4X were up

Read more
30 Apr 2019 12:59

C4X Discovery Interim Loss Widens, Focuses On Inking Deals

LONDON (Alliance News) - C4X Discovery Holdings PLC said on Tuesday it had a "strong" first half, though its loss widened on higher research and development costs.The drug firm to

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.